STAAR Surgical STAA 深 沪
等待开盘 10-03 09:30:00 美东时间
27.42
+0.240
+0.88%
华盛通- 最 高27.45
- 今 开27.12
- 成交量 43.29万股
- 最 低 27.11
- 昨 收 27.18
- 总市值 13.59亿
- 52周最高 33.28
- 市盈率 静 --
- 换手率 0.00%
- 52周最低 13.50
- 委 比 18.53%
- 总股本 4955.30万
- 历史最高 163.08
- 量 比 0.72
- 振 幅 1.25%
- 历史最低 4.48
- 每 手 1
- 风险率 5.86%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多美股收盘：美股9月收官！本月道指累涨1.87%，标普累涨3.53%，双双连涨五个月
美股9月收官！本月道指累涨1.87%，标普累涨3.53%，双双连涨五个月；英伟达隔夜涨2.6%再创新高；制药股走高，辉瑞涨近7%，默沙东涨超6%，礼来涨超5%>>
10-01 09:04
Alcon And STAAR Announce Expiration Of HSR Waiting Period For Acquisition
Alcon (NYSE:ALC), the global leader in eye care dedicated to helping people see brilliantly, and STAAR Surgical Company (NASDAQ:STAA) ("STAAR"), the manufacturer of the Implantable Collamer® Lens (ICL), today
09-30 20:43
爱尔康斥资15亿美元收购STAAR Surgical
转自：财联社 【爱尔康斥资15亿美元收购STAAR Surgical】财联社9月30日电，爱尔康公司宣布将以每股28美元价格收购STAAR Surgical公...
09-30 20:37
Metsera ultra-long acting GLP-1 MET-097i excels in mid-stage trial
Metsera's (NASDAQ:MTSR) MET-097i, a long-acting GLP-1 medicine for obesity that could be dosed as infrequently as once a month, demonstrated significant weight loss in phase 2b. In VESPER-1, after 28 ...
09-30 04:59
Rocket Lab and Synspective strike another launch deal
Rocket Lab (NASDAQ:RKLB) said on Monday that it has secured a second multi-launch contract with Synspective, a Synthetic Aperture Radar satellite data and analytics company from Japan. The new contra...
09-30 04:41
这家“全球第一”，斥资4.27亿扩建工厂！
（来源：医疗器械创新网） 作为全球最大的眼科器械公司，爱尔康（Alcon）在手术与视力保健双领域均占据全球第一的市场地位。 爱尔康扩厂：全球眼科巨头的...
09-29 17:02
STAAR Surgical pushes for all-cash merger with Alcon
STAAR Surgical Company (NASDAQ:STAA) said in a presentation today that its $28.00 per share all-cash merger with Alcon provides its stockholders compelling, certain, cash value at a significant premiu...
09-27 02:26
Staar Surgical Announces Proposed Merger with Alcon
An announcement from Staar Surgical ( ($STAA) ) is now available. On September ...
09-26 21:27
Yunqi Capital Investment Management Firm And 5.1% Shareholder Of STAAR Surgical Announced Its Opposition To The Company's Proposed Sale To Alcon On The Terms Announced On August 5, 2025
Issues Open Letter to Shareholders Outlining Its Belief that the Proposed Merger Materially Undervalues STAARContends that STAAR's Board Failed In Its Responsibilities by Not Running a Thorough Process and Relying on
09-22 18:07
STAAR Surgical Urges Stockholders To Vote "FOR" $28/Share Alcon Merger
Provides Greater Value than STAAR Could Achieve on a Standalone Basis in the Foreseeable Future and is the Best Path Forward for STAAR StockholdersFiles Definitive Proxy Materials and Mails Letter to STAAR
09-16 21:51
